💊
Dasatinib Accord
dasatinib (anhydrous)
Förstadscellslymfoblastleukemi-lymfom;Leukemi, myelogen, kronisk, BCR-ABL-positiv
🚫 Dragen tillbaka
Generisk
✅
Inga aktiva aviseringar
Denna medicin har inga pågående brister, säkerhetsbrev eller återkallelser.
Vad det används till
Dasatinib Accord is indicated for the treatment of adult patients with: • Ph+ acute lymphoblastic leukaemia (ALL) with resistance or intolerance to prior therapy. Dasatinib Accord is indicated for the treatment of paediatric patients with: • newly diagnosed Ph+ ALL in combination with chemotherapy.
⚠️ Patientsäkerhet
No
Officiell EMA-sida
https://www.ema.europa.eu/en/medicines/human/EPAR/dasatinib-accord